Cassava Sciences (NASDAQ: SAVA) is a pharmaceutical company dedicated to developing novel treatments for Alzheimer's disease. With a focus on targeting the underlying causes of neurodegeneration, Cassava Sciences is at the forefront of research and innovation in the field of neurology. Through its cutting-edge drug development programs, the company aims to address the urgent need for effective therapies to combat this debilitating condition and improve the quality of life for patients and their families.

Refer new talent to Cassava Sciences